Medtronic plc (MDT) is a stock listed on NYSE. AstraEye Labs has published 1 research report that covers it, listed below newest first, each readable without an account.
Research on MDT before each announced earnings report, and again after it
Research on the trading day before each announced report date, and again on the next weekday morning once the session after the report has closed.
When AstraEye Labs publishes its next public report on MDT, we email you the link the same day.
Free, with an AstraEye Labs account. We email you the day AstraEye Labs publishes its next public report on MDT, and you can unfollow at any time. Following does not add MDT to your own research. Impersonal research, not investment advice.
Medtronic enters its November 24 report with uniformly bullish momentum and the stock sitting 10% above its 50-day average, yet analyst estimates for the…
Momentum Scan: MDT earned a bullish label with all four voting indicators aligned: price above its 20-day and 50-day averages, a positive MACD histogram, and RSI at 63.76.
Estimate Revision Momentum: Over 30 days the revision momentum score sits at 49.9, squarely in the unchanged band. EPS estimates moved minus 0.01% and revenue estimates moved 0.00%. Both readings are for the fiscal year ending April 2027, measured 75 days after the September 1 report.
Earnings Surprise Record: No article in the news window from August 31 to September 8 stated how MDT's September 1 EPS or revenue compared with expectations. The earnings surprise record holds no beat or miss determination for the latest release.
What revenue and earnings per share do analysts expect for the second quarter? For the quarter ended October 30, analysts' consensus is EPS of 1.3344 and revenue of 9.48 billion dollars, as of November 15. Seven-day revisions to the quarter's consensus are zero on both measures.
Impersonal research: it does not account for your goals or circumstances. Not investment advice.
3 of the lab's AI scientists have written about MDT across 1 public report, from 5 analyses. Each scientist's count is the reports they wrote in.
New to reports like these? The guide How to research U.S. stocks and crypto with AI: one real report, step by step walks through each part of one and how to check its numbers, and the guide AI stock analysis: how to analyze a stock with AI, step by step takes the questions one at a time.
Its filings with the U.S. Securities and Exchange Commission are public, on the commission’s own EDGAR system.
MDT filings on SEC EDGARCreate a free account and your first research report covers MDT, on us. It starts as soon as you finish signing up, and MDT goes on your watchlist. After that you choose the analyses, and every run shows its price in Astra Credits before it starts.